How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Close this folder6 DEVELOPING SPECIFIC INFORMATION SECTIONS
View the documentCreating locally important appendices
Close this folderAdopting appendices from the WHO model formulary
View the documentAdditions
View the documentDeletions
Open this folder and view contentsWorking with a master document in Microsoft Word® to create a table of contents and index
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Additions

When a new monograph is developed for the NF, where the specific information is to be included in the appendices, this material should also be written at the time of development. In the case of interactions, the new entry would be inserted under the medicine being characterized in the new monograph as well as under the interacting medicines (reversals) (see the example of epoetin in Box 6.1). In the other appendices, additional information would be inserted into the existing alphabetical lists as appropriate.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014